Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000094.xml
Z Gastroenterol 2017; 55(07): 685-686
DOI: 10.1055/s-0043-106861
DOI: 10.1055/s-0043-106861
Kommentiertes Referat
Regorafenib – Revolution der systemischen Therapieoptionen beim HCC?
Regorafenib – a revolution in the systemic treatment options of HCC?Further Information
Publication History
Publication Date:
24 April 2017 (online)
Bruix J, Qin S, Merle P, et al. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomized, double-blind, placebo-controlled, phase 3 trial. Lancet 2017, 389: 56 – 66